Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: Cost-utility and its determinants

International Journal of Cardiology

Volumn 182, Issue , 2015, Pages 321-328

  Ribera, Aida ^a,b   Slof, John ^c   Andrea, Rut ^d   Falces, Carlos ^d   Gutiérrez, Enrique ^e   Del Valle Fernández, Raquel ^f   Morís De La Tassa, César ^f   Mota, Pedro ^g   Oteo, Juan Francisco ^h   Cascant, Purificació ^a,b   Altisent, Omar Abdul Jawad ^a   Sureda, Carlos ^a   Serra, Vicente ^a   García Del Blanco, Bruno ^a   Tornos, Pilar ^a   Garcia Dorado, David ^a   Ferreira González, Ignacio ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Cost effectiveness; Surgical aortic valve replacement; Transcatheter aortic valve replacement

Indexed keywords

AGED; AORTIC VALVE STENOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; ECONOMICS; EPIDEMIOLOGY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART VALVE REPLACEMENT; HOSPITAL COST; HUMAN; MALE; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPAIN; TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL COSTS; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84947201433     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.12.109     Document Type: Article

References (21)

1. P. Indraratna, S.C. Ang, H. Gada, T.D. Yan, C. Manganas, P. Bannon, and C. Cao Systematic review of the cost-effectiveness of transcatheter aortic valve implantation J. Thorac. Cardiovasc. Surg. 148 2014 509 514
2. M.R. Reynolds, E.A. Magnuson, Y. Lei, K. Wang, K. Vilain, H. Li, J. Walczak, D.S. Pinto, V.H. Thourani, L.G. Svensson, M.J. Mack, D.C. Miller, L.E. Satler, J. Bavaria, C.R. Smith, M.B. Leon, and D.J. Cohen Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A) J. Am. Coll. Cardiol. 60 2012 2683 2692
3. D. Mylotte, R.L.J. Osnabrugge, S. Windecker, T. Lefevre, P. De Jaegere, R. Jeger, P. Wenaweser, F. Maisano, N. Moat, L. Sondergaard, J. Bosmans, R.C. Teles, G. Martucci, G. Manoharan, E. Garcia, N.M. Van Mieghem, A.P. Kappetein, P.W. Serruys, R. Lange, and N. Piazza Transcatheter aortic valve replacement in Europe adoption trends and factors influencing device utilization J. Am. Coll. Cardiol. 62 2013 210 219
4. F. Roques, P. Michel, A.R. Goldstone, and S.A.M. Nashef The logistic EuroSCORE Eur. Heart J. 24 2003 881 882
5. H. Gada, S. Agarwal, and T.H. Marwick Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model Ann. Cardiothorac. Surg. 1 2012 145 155
6. J.M. Ramos-Goni, and O. Rivero-Arias eq5d: a command to calculate index values for the EQ-5D quality-of-life instrument Stata J. 11 2011 120 125
7. D. Polsky, and H. Glick Costing and cost analysis in randomized controlled trials: caveat emptor Pharmacoeconomics 27 2009 179 188
8. S.G. Thompson, and J.A. Barber How should cost data in pragmatic randomised trials be analysed? BMJ 320 2000 1197 1200
9. A. Briggs Statistical methods for cost-effectiveness analysis alongside clinical trials A.M. Jones, The Elgar Companion to Health Economics 2006 Edgar Elgar Cheltenham
10. T.A. Fairbairn, D.M. Meads, C. Hulme, A.N. Mather, S. Plein, D.J. Blackman, and J.P. Greenwood The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk Heart 99 2013 914 920
11. R.L. Osnabrugge, S.J. Head, T.S. Genders, N.M. Van Mieghem, P.P. De Jaegere, R.M. van der Boon, J.M. Kerkvliet, B. Kalesan, A.J. Bogers, A.P. Kappetein, and M.G. Hunink Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients Ann. Thorac. Surg. 94 2012 1954 1960
12. M. Sabate, S. Canovas, E. Garcia, A.R. Hernandez, L. Maroto, J.M. Hernandez, J.H. Alonso Briales, A.J. Munoz Garcia, E. Gutierrez-Ibanes, and J. Rodriguez-Roda In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010-2011 Rev. Esp. Cardiol. 66 2013 949 958
13. I. Pascual, D. López-Otero, A.J. Muñoz-García, J.H. Alonso-Briales, P. Avanzas, and C. Morís Safety and Efficacy of Transcatheter Aortic Valve Implantation in Nonagenarian Patients Rev. Esp. Cardiol. 67 2014 7583 7584
14. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, L.G. Svensson, E.M. Tuzcu, J.G. Webb, G.P. Fontana, R.R. Makkar, M. Williams, T. Dewey, S. Kapadia, V. Babaliaros, V.H. Thourani, P. Corso, A.D. Pichard, J.E. Bavaria, H.C. Herrmann, J.J. Akin, W.N. Anderson, D. Wang, and S.J. Pocock Transcatheter versus surgical aortic-valve replacement in high-risk patients N. Engl. J. Med. 364 2011 2187 2198
15. M.R. Reynolds, E.A. Magnuson, K.J. Wang, V.H. Thourani, M. Williams, A. Zajarias, C.S. Rihal, D.L. Brown, C.R. Smith, M.B. Leon, and D.J. Cohen Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (Cohort A) J. Am. Coll. Cardiol. 60 2012 548 558
16. S.V. Arnold, J.A. Spertus, Y. Lei, P. Green, A.J. Kirtane, S. Kapadia, V.H. Thourani, H.C. Herrmann, N. Beohar, A. Zajarias, M.J. Mack, M.B. Leon, and D.J. Cohen How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial Circ. Cardiovasc. Qual. Outcomes 6 2013 591 597
17. D.H. Adams, J.J. Popma, M.J. Reardon, S.J. Yakubov, J.S. Coselli, G.M. Deeb, T.G. Gleason, M. Buchbinder, J. Hermiller Jr., N.S. Kleiman, S. Chetcuti, J. Heiser, W. Merhi, G. Zorn, P. Tadros, N. Robinson, G. Petrossian, G.C. Hughes, J.K. Harrison, J. Conte, B. Maini, M. Mumtaz, S. Chenoweth, and J.K. Oh Transcatheter aortic-valve replacement with a self-expanding prosthesis N. Engl. J. Med. 370 2014 1790 1798
18. M. Neyt, H. Van Brabandt, S. Devriese, and S.S. Van De A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population BMJ Open 2 2012
19. S.V. Arnold, M.R. Reynolds, Y. Lei, E.A. Magnuson, A.J. Kirtane, S.K. Kodali, A. Zajarias, V.H. Thourani, P. Green, J. Rodes-Cabau, N. Beohar, M.J. Mack, M.B. Leon, and D.J. Cohen Predictors of poor outcomes after transcatheter aortic valve replacement results from the PARTNER (Placement of Aortic Transcatheter Valve) trial Circulation 129 2014 2682 2690
20. P. Wenaweser, S. Stortecky, S. Schwander, D. Heg, C. Huber, T. Pilgrim, S. Gloekler, C.J. O'Sullivan, B. Meier, P. Juni, T. Carrel, and S. Windecker Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation Eur. Heart J. 34 2013 1894 1905
21. N.M. Van Mieghem, and P.W. Serruys The art of risk stratification in TAVI Eur. Heart J. 34 2013 1859 1861